Brief: Cantargia Presents Positive Results For Nadunolimab At Aacr 2023 Including New Clinical Data In Pancreatic Cancer

Cantargia AB

14/03/2023 22:46

March 14 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA PRESENTS POSITIVE RESULTS FOR NADUNOLIMAB AT
AACR 2023
INCLUDING NEW CLINICAL DATA IN PANCREATIC CANCER
    * CANTARGIA AB - RESULTS FROM PHASE I/IIA CLINICAL TRIAL
CANFOUR
HAVE SHOWN STRONGER EFFICACY OF COMBINATION THAN EXPECTED FROM
CHEMOTHERAPY ALONE

Source text for Eikon:  ID:nPreP11wqa 
Further company coverage:  CANTA.ST 

 ((Reuters.Briefs@thomsonreuters.com;))